Trend-Following Backtester · Guide · backtest 한국어

equity · US

Globus Medical, Inc. backtest

10 trend-following strategies were compared on the full daily history of Globus Medical, Inc.. 0 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester.

Data 2012-08-03 ~ 2026-07-31daily bars 3,517 (14.0 years)Costs 0.5%Venue XNYSMonthly snapshot 2026-07-31

Results by strategy

0 of 10 beat buy and hold (CAGR 13.4%, drawdown -47.9%).

Sharpe leader (same as main): Supertrend — CAGR 11.6%, MDD -48.6%, Sharpe 0.55, 60% exposure.

No strategy retained at least 75% of buy-and-hold CAGR while reducing drawdown by both 20% relatively and 5 percentage points absolutely.

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=13, mult=5
11.6%-48.6%0.550.244.7x3860%
Keltner 채널 돌파
emaPeriod=17, atrPeriod=15, mult=4
3.3%-10.4%0.540.311.6x106%
Donchian 채널 돌파
entryN=45, exitN=33
9.9%-43.0%0.500.233.8x3459%
볼린저 밴드 돌파
n=47, k=3.5
4.5%-18.1%0.490.251.8x1815%
SMA 크로스오버
fast=27, slow=71
9.0%-43.0%0.470.213.4x5459%
Parabolic SAR
step=0.005, maxStep=0.28
7.9%-37.6%0.420.212.9x11756%
ROC 모멘텀
n=77, threshold=0
7.2%-51.5%0.410.142.6x12058%
EMA 크로스오버
fast=44, slow=72
5.7%-45.9%0.350.122.2x3459%
MACD
fast=17, slow=54, signal=21
2.2%-62.8%0.210.031.4x15349%
ADX / DI 방향성
period=35, threshold=14
0.2%-44.1%0.090.001.0x9832%
Buy and hold13.4%-47.9%0.530.285.8x1100%
1x 2013 2015 2017 2019 2021 2023 2025 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -12% -24% -36% -49% 2013 2015 2017 2019 2021 2023 2025 Buy and holdSupertrend
Supertrend maximum drawdown -48.6% (2021-09-08 → 2023-12-15), recovered after 1,521 days.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were carried forward from the latest full optimization and replayed on this monthly dataset. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-optimize the same period and setupAll asset reports

Read next